To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05849610
Title Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma (GEM-TECTAL)
Acronym GEM-TECTAL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Germans Trials i Pujol Badalona Spain Details
Hospital Clinic i Provincial de Barcelona Barcelona Spain Details
Hospital Doce de Octubre Madrid 28041 Spain Details
Hospital Virgen de la Arrixaca Murcia Spain Details
Clinica Universidad de Navarra Pamplona Spain Details
Hospital Universitario de Salamanca Salamanca Spain Details
H. Universitario Marqués de Valdecilla Santander Spain Details
Complejo Hospitalario Santiago (CHUS) Santiago De Compostela Spain Details
Hospital Vírgen del Rocío Sevilla Spain Details
Hospital Universitari i Politecnic la Fe Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field